The FDA’s Project Optimus has fundamentally changed how sponsors select doses in oncology, moving from the Maximum Tolerated Dose to the Optimal Biological Dose. Statistical designs have advanced quickly, although their impact and applicability in achieving the ultimate goals of dose optimization remain unclear. In practice, the operational reality has not yet caught up, leaving dose decisions reliant on spreadsheets, lagging data exports, and ad hoc reconciliation across systems.

This webinar will walk through a modern dose-finding toolkit from BOIN to efficacy-toxicity designs to seamless Phase I/II and demonstrate how eClinical technology can support adaptive oncology trials in practice.

Key learnings:

  • Understand the shift in oncology dose selection: why Project Optimus is moving the field from maximum tolerated dose toward optimal biological dose.
  • Get oriented in the modern dose-finding toolkit: including BOIN, efficacy-toxicity designs, and seamless Phase I/II approaches.
  • Recognize the practical implementation gap: how dose decisions can still be slowed by spreadsheets, delayed data exports, and manual reconciliation across systems.
  • See how adaptive oncology trials can be operationalized in practice: using a live cohort tracker that brings DLT capture, PK review, and Safety Review Committee decisions into one workflow.
  • Leave with a clearer view of what is needed for effective dose optimization: combining sound statistical design with timely, integrated trial operations.

Speakers:

Manuel Neukum

Manuel Neukum

CEO, AB Cube Germany

Leandro Garcia Barrado

Leandro Garcia Barrado

Principal Statistical Scientist, IDDI

Related Podcast Series

When Methodology Meets Technology explores how intelligent trial design and digital agility can work together to address the growing complexity of clinical research. Across three episodes, experts from IDDI and Marvin EDC discuss how statistical innovation, connected data and flexible technology can help translate advanced trial designs into clinical practice.

  • Episode 1: From Protocol to Platform

    Explore how adaptive trial designs combine statistical methodology and flexible technology to support smarter, more efficient clinical trials.

    Watch Here
  • Episode 2: Turning Data Into Decisions

    Discover how group sequential designs and real-time reporting work together to support reliable interim decisions.

    Watch Here
  • Episode 3: From Data to Delivery

    Learn how statistical strategy and EDC technology can build trustworthy evidence and support readiness for accelerated approvals.

    Watch Here

Back to Events

When every data point represents a patient, accuracy and integrity aren’t optional — they’re everything. That’s why it’s IDDI.

Start Now